Abstract | OBJECTIVE:
NAFLD is a complex disease marked by cellular abnormalities leading to NASH. NAFLD patients manifest low hepatic levels of CEACAM1, a promoter of insulin clearance. Consistently, Cc1-/- null mice displayed spontaneous hyperinsulinemia/ insulin resistance and steatohepatitis. Liver-specific reconstitution of Ceacam1 reversed these metabolic anomalies in 8-month-old Cc1-/-xliver+ mice fed a regular chow diet. The current study examined whether it would also reverse progressive hepatic fibrosis in mice fed a high-fat (HF) diet. METHODS: 3-Month-old mice were fed a high-fat diet for 3-5 months, and metabolic and histopathological analysis were conducted to evaluate their NASH phenotype. RESULTS: CONCLUSIONS: Restored metabolic and histopathological phenotype of HF-fed Cc1-/-xliver+xliver+ assigned a critical role for hepatic CEACAM1 in preventing NAFLD/NASH including progressive hepatic fibrosis.
|
Authors | Raghd Abu Helal, Lucia Russo, Hilda E Ghadieh, Harrison T Muturi, Suman Asalla, Abraham D Lee, Cara Gatto-Weis, Sonia M Najjar |
Journal | Metabolism: clinical and experimental
(Metabolism)
Vol. 121
Pg. 154801
(08 2021)
ISSN: 1532-8600 [Electronic] United States |
PMID | 34058224
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 Elsevier Inc. All rights reserved. |
Chemical References |
- Carcinoembryonic Antigen
- Ceacam1 protein, mouse
- Insulin
|
Topics |
- Animals
- Carcinoembryonic Antigen
(genetics, physiology)
- Diet, High-Fat
- Insulin
(metabolism)
- Insulin Resistance
(genetics)
- Lipid Metabolism
(genetics)
- Liver Cirrhosis
(genetics, metabolism, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
|